2014
DOI: 10.1080/15332985.2014.894487
|View full text |Cite
|
Sign up to set email alerts
|

Will the Treatment Protocols for Schizophrenia be Changing Soon?

Abstract: In recent decades the understanding of the core physiology giving rise to schizophrenia has advanced markedly. Current pharmacological interventions fail to target the core problems in schizophrenia. Several important outcome studies call into question whether current medications actually make long term outcomes worse. These new studies follow the recognized negative side effect of anti-psychotic drugs. The implication of these findings for social workers who work with the seriously mentally ill are discussed.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 91 publications
(99 reference statements)
0
1
0
Order By: Relevance
“…Likewise, outcomes vary by country, and long-term patient outcomes in countries with poor or moderate economies (where psychiatric medications are scarce) are better than long-term outcomes in wealthy countries (where psych meds are prevalent) (Saha, et al, 2005;Sartorius, et al, 1996;Warner, 1983). A few professionals recommend a new course of treatment that de-emphasizes psychiatric medications for long-term care (Littrell, 2014). Notwithstanding, the evidence-basis for this type of assertion remains indeterminate from lack of data.…”
Section: Medicationmentioning
confidence: 99%
“…Likewise, outcomes vary by country, and long-term patient outcomes in countries with poor or moderate economies (where psychiatric medications are scarce) are better than long-term outcomes in wealthy countries (where psych meds are prevalent) (Saha, et al, 2005;Sartorius, et al, 1996;Warner, 1983). A few professionals recommend a new course of treatment that de-emphasizes psychiatric medications for long-term care (Littrell, 2014). Notwithstanding, the evidence-basis for this type of assertion remains indeterminate from lack of data.…”
Section: Medicationmentioning
confidence: 99%